PCRB is interested in research that promotes optimal use of breast, cervical, and colorectal cancer screenings in populations. Optimal use balances the benefit of screening for people who will get cancer in their lifetime against the harms to those who will not get cancer.
The branch encourages research that explores multiple levels of influence on screening decisions and processes. Relevant studies may include the following:
- Development of metrics of screening overuse and underuse
- Assessment of the screening delivery process to provide guidance about when to continue or end screening
- Investigation of genetic testing for cancer susceptibility and the wider implications of such testing in primary care settings
- Testing of new and innovative methods, theories and strategies to improve the quality of the cancer screening process from a multilevel perspective
- Examinations of multilevel influences on follow-up to abnormal cancer screening tests